NANO4 in partnership with CUF Hospitals and Clinics network initiates validation of diagnostics platform for Chronic Myeloid Leukaemia

news


NANO4 Global develops molecular nanodiagnostics solutions. NANO4 Global is now bringing fast, decentralised and affordable molecular diagnostics solutions in cancer. The collaboration with CUF hospitals, through its network CUF Oncology, the largest private cancer care network in Portugal, will allow the clinical validation of NANO4 CML for the laboratory diagnostics of Chronic Myeloid Leukaemia. This an important step towards consolidating NANO4 Global market launch.



Media

News & Updates
  July  2021
NANO4 in partnership with CUF Hospitals and Clinics network initiates validation of diagnostics platform for Chronic Myeloid Leukaemia
  November  2019
NANO4 was recognized with the NOVA SPIN-OFF seal